POINT Biopharma Global Inc

NASDAQ:PNT  
7.86
-0.45 (-5.42%)
Earnings Announcements

POINT Biopharma Reports Q3 Loss Per Share $0.19

Published: 11/12/2021 13:41 GMT
POINT Biopharma Global Inc (PNT) - Point Biopharma Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.19.
Current Cash and Cash Equivalents Are Expected to Fund Operations Into Q1 of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.